advertisement
Stamer WD 20
Showing records 1 to 20 | Display all abstracts from Stamer WD92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
Cassidy PS
Molecular therapy. Methods & clinical development 2021; 20: 86-94
92680 Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Li G
eLife 2021; 10:
92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
Kelly RA
Molecular therapy. Methods & clinical development 2021; 20: 86-94
92680 Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Lee C; Read AT
eLife 2021; 10:
92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
Reina-Torres E; Sherwood JM
Molecular therapy. Methods & clinical development 2021; 20: 86-94
92680 Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Wang K
eLife 2021; 10:
92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
Humphries MM
Molecular therapy. Methods & clinical development 2021; 20: 86-94
92680 Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Ha J; Kuhn M
eLife 2021; 10:
92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
Kiang AS; Farrar GJ
Molecular therapy. Methods & clinical development 2021; 20: 86-94
92680 Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Navarro I
eLife 2021; 10:
92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
O'Brien C
Molecular therapy. Methods & clinical development 2021; 20: 86-94
92680 Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Cui J
eLife 2021; 10:
92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
Campbell M
Molecular therapy. Methods & clinical development 2021; 20: 86-94
92680 Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Young K
eLife 2021; 10:
92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
Stamer WD
Molecular therapy. Methods & clinical development 2021; 20: 86-94
92680 Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Gorijavolu R; Sulchek T
eLife 2021; 10:
92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
Overby DR
Molecular therapy. Methods & clinical development 2021; 20: 86-94
92680 Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Kopczynski C
eLife 2021; 10:
92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
Humphries P; O'Callaghan J
Molecular therapy. Methods & clinical development 2021; 20: 86-94
92680 Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Farsiu S; Samples J; Challa P; Ethier CR; Stamer WD
eLife 2021; 10:
